Liposome-based nanodrug development
The company focuses on developing nanodrugs based on liposomes.
Source: LinkedIn company description · Retrieved October 13, 2026
LipoCure is a start-up focused on developing liposome-based nanodrugs.
Its pipeline includes projects close to clinical trials and other projects in preclinical stages. The active pharmaceuticals used in its drugs are generic.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company focuses on developing nanodrugs based on liposomes.
Source: LinkedIn company description · Retrieved October 13, 2026
The pipeline includes a long-circulating, inflammation-targeted steroidal nanoliposomal drug intended for anti-inflammatory and anti-cancer use.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 18, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.